Current Research

NEW Patient-reported Adverse Events from Osteopathic Manipulative Treatment

An observational study evaluating the incidence and severity of OMT adverse events

Principal Investigator:  Jane C. Johnson and Brian F. Degenhardt

An essential part of healthcare is to accurately characterize and monitor the safety and efficacy of all medical treatments. While the OMM Utilization Study has allowed us to evaluate aspects of both the effectiveness of and adverse events associated with OMT, the scope of data on adverse events from this study is limited. Since there has been minimal rigorous research produced by the osteopathic profession on adverse events from OMT, we were requested to address this deficiency and to consider expanding our research in this area. DO-Touch.NET has prioritized research focusing on adverse events. The OMT Adverse Events Study will look at the incidence and severity of OMT adverse events and examine the relationship of these adverse events to the techniques used and the body regions treated. The study has been designed to be simple so all members can easily implement it at their offices. We would like to talk with all members about the study so you can see just how easy it would be to contribute to important, meaningful, osteopathically-relevant research. Please contact Lisa Norman, Network Manager, at 660-626-2443 or lnorman@atsu.edu, if you are interested.

Study Objectives:

-Determine what is the incidence of adverse events from osteopathic manipulative treatment
-Determine if there are individual osteopathic techniques in particular body regions that have higher incidences of adverse events than other techniques or body regions

Study Design: A prospective observational cohort research study

Potential Benefits to Participants:  This is an opportunity to contribute to a database that will lay the foundation for the long-term online data collection of OMT adverse event to assist with increased knowledge to benefit general society.

Potential Risks to Participants:  No significant risks are identified.  There is minimal, if any, risk to confidentiality since all records are coded in a generalized manner to fully protect anonymity.

Patient Participant Inclusion Criteria:

– Adults, 18 years or older – Receive OMT by participating provider – Give informed consent

Patient Participant Exclusion Criteria:

– Patients that do not receive OMT – Patients that refuse to participate – Patients with difficulty communicating in English, Spanish, French, German, or Portugues

 

Use and Effectiveness of OMM in the Clinical Setting

An observational study evaluating the effects of OMT on specific conditions and disease processes

Principal Investigator:  Brian F. Degenhardt, D.O.

The specific aim of this research study is to evaluate the utilization, effectiveness, and safety of OMT using data collected from participants receiving OMT in the clinical setting. Data is collected directly from participants and physicians regarding history of complaints, severity of symptoms, current and past treatments, physical examination findings, diagnoses, OMT treatment performed and participant immediate response to OMT. Participants’ symptoms are further evaluated on a daily basis for seven days and one week after treatment. DO-Touch.NET will oversee this study through its organization as defined in its policy and procedures. As an observational study, this study will not impact any aspect of the care received by the patient participants.

Study Objectives:

– Determine the scope of conditions currently being treated with OMT – Identify conditions that are responsive and unresponsive to OMT – Determine which techniques are most beneficial in treating conditions responsive to OMT – Determine if certain patient characteristics are present in those who are responsive to OMT – Determine which physicians have consistently positive outcomes with OMT for certain conditions

Study Design: A prospective, longitudinal observational research study

Potential Benefits to Participants:  This is an opportunity to contribute to a database about OMT to assist with increased knowledge to benefit general society.

Potential Risks to Participants:  No significant risks are identified.  There is minimal, if any, risk to confidentiality since all records are coded in a generalized manner to fully protect anonymity.

Patient Participant Inclusion Criteria:

– Adults, 18 years or older – Receive OMT by participating provider – Give informed consent – Able to communicate in English and have the ability to provide accurate information

Patient Participant Exclusion Criteria:

– Patients that do not receive OMT – Patients that refuse to participate – Patients with difficulty communicating in English, have dementia, or have psychological conditions that may impact their ability to provide accurate information – Research team members and participating clinic employees

Project Sites 

 

midwestern    rockymtn    OC4C    CPHC   midwestern

ATSU-OMM  Kohn_Group  ATSU-KFM

jefferson park  metrohealth  Brooks

Feely PRNK Capital Region

beecavesNMHC